RhoA/Rho kinase: a novel therapeutic target in diabetic complications.
Zhou
Hong
H
Department of Endocrinology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China.
Li
Yong-jun
YJ
D000818:Animals; D009202:Cardiomyopathies / Q000209:etiology; D048909:Diabetes Complications / Q000209:etiology* / Q000628:therapy; D006801:Humans; D012735:Sexual Dysfunction, Physiological / Q000209:etiology; D015398:Signal Transduction; D001745:Urinary Bladder Diseases / Q000209:etiology; D054460:rho-Associated Kinases / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000502:physiology*; D020742:rhoA GTP-Binding Protein / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000502:physiology*
D054460:rho-Associated Kinases; D020742:rhoA GTP-Binding Protein